Revenues from Global Sales of Vocal Biomarkers are Foreseen to Surpass US$ 390 Mn by 2027-end

Revenues from Global Sales of Vocal Biomarkers are Foreseen to Surpass US$ 390 Mn by 2027-end
Vocal Biomarker Market report by “Fact.MR – Market Research And Insights”
A recently compiled report of Fact.MR envisages the global sales of a vocal biomarkers to record a spectacular 23.3% CAGR between the forecast period 2018 and 2027

Award winning market research company Fact.MR has conducted a study on the global vocal biomarker market. As per the analysis, recent breakthroughs in the healthcare sector has fostered the sales for vocal biomarkers. Long-term expansion prospects are expected to remain positive, experiencing high growth rate until 2027.

According to the U.S. National Library of Medicine, there was a 39% of increase in the death rate due to the neurological disorder. Neurological disorders were the leading cause of DALYs (Disability Adjusted Life Years) and second leading cause of deaths. Hence, accelerating the production for vocal biomarkers.

According to the study, researchers are focusing on voice-based biomarkers. Start-ups are using Artificial Intelligence (AI) and machine learning (ML) to develop enhanced tools to detect a wide range of diseases. For instance, Vocalis Health, a start-up is working with developers to identify voice-based biomarkers for pulmonary hypertension.

“Manufacturers are accelerating their research and development capacities for more enhanced technology to detect neurological diseases like Alzheimer’s and Parkinson’s. Healthcare professionals and manufacturing companies are using the AI and ML tools to propel the production for vocal biomarkers,” says the Fact.MR analyst.   

For More Valuable Information on Regional Market Dynamics, Request a Report Sample

vocal biomarker market

Key Takeaways

  • Global vocal biomarker to exhibit a spectacular growth at nearly 23.3% CAGR through 2021
  • Contract research organizations (CROs) to emerge as highly sought after vocal biomarker drugs availability channel
  • North America to retain dominance for vocal biomarker, attributed to advanced technology used by manufacturing companies
  • Psychiatric disorders to emerge as a lucrative tool
  • U.S. to emerge as highly lucrative market, fueled by tie-ups of US government agencies with voice-based companies

Prominent Drivers

  • Increasing cardiovascular and psychological diseases to foster the sales
  • Rising demand for MRI, CT, and X-Ray to propel the growth of vocal biomarker
  • Emerging applications in healthcare and life sciences to deploy voice assistant platforms in clinical trial settings, penetrating the vocal biomarker market

Key Restraints

  • Low stability over long period for patients with chronic neurological diseases such as Alzheimer’s to hamper sales
  • Expensive techniques used in vocal biomarker’s application resulting in healthcare burden on economy, thus limiting penetration

Need more information about Report Methodology? Ask here

Competitive Landscape

Prominent vocal biomarker solutions providers include Beyond Verbal Communication Ltd., Sonde Health Inc., IBM Corporation, Cogito Corporation, and US Cargo Control among others. Variety of expansion strategies and advanced development are being deployed by the aforementioned market players.

In October 2020, Mayo Clinic collaborated with Vocalis Health for clinical development of vocal biomarkers. The AI-based company announced a collaboration to research and develop new voice voice-based tools for screening, detecting and monitoring patient’s health.

More Insights on the Vocal biomarker Market

In its latest report, Fact.MR offers unbiased analysis of the global vocal biomarker market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of technique (frequency, amplitude, error rate, vocal rise or fall time, phonation time, voice tremor, pitch and other types), end-user (hospitals & clinics, CROs, academic & research center, and other end-users), indication (psychiatric disorders, respiratory disorders, cardiovascular disorders, traumatic brain injury, neurological disorders and others), and region (North America, Latin America, Europe, Japan, APEJ, and MEA).

Read Fact.MR Exclusive Article on Emerging Frontiers in the Global Dental Industry

About Us: 

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner. 


Neha Bhosle

US Sales Office:

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Media Contact
Company Name: Fact.MR
Contact Person: Neha Bhosle
Email: Send Email
Phone: 6282511583
Address:US Sales Office: 11140 Rockville Pike
City: Rockville
State: Maryland
Country: United States